Clinical context
This client remains hypotensive after adequate crystalloid resuscitation, with a mean arterial pressure of
58 mmHg. In septic shock, persistent hypotension despite fluid loading indicates loss of vascular tone from vasodilation and relative hypovolemia. The next step is a vasopressor to restore perfusion pressure, and the target is a mean arterial pressure of at least
65 mmHg [4].
Why norepinephrine is first-line
Norepinephrine is the recommended first-line vasopressor in septic shock because it provides strong alpha-adrenergic vasoconstriction while also supporting cardiac output through modest beta-adrenergic effects. It raises systemic vascular resistance and improves organ perfusion pressure without excessively increasing myocardial oxygen demand. Current evidence continues to support norepinephrine as the initial vasopressor, with early initiation shortening hypotension duration and reducing fluid requirements
[2][3][4].
Stepwise vasopressor approach
The vasopressor strategy in septic shock follows a clear sequence. Norepinephrine is started first and titrated to a mean arterial pressure of
65 mmHg. If the pressure remains inadequate despite escalating norepinephrine,
vasopressin is added as a second agent rather than continuing to push norepinephrine to very high doses.
Adrenaline is reserved for refractory hypotension when the combination of norepinephrine and vasopressin is insufficient.
Dobutamine is an inotrope used for low cardiac output, not a first-line vasopressor for restoring vascular tone
[1][2].
| Agent | Primary action | Role in septic shock |
|---|
| Norepinephrine | Alpha-1 vasoconstriction with mild beta-1 inotropy | First-line vasopressor; titrate to MAP 65 mmHg |
| Vasopressin | V1 receptor vasoconstriction | Added to norepinephrine to reduce catecholamine dose |
| Adrenaline | Beta and alpha agonism | Added if norepinephrine plus vasopressin still inadequate |
| Dobutamine | Beta-1 inotropy | For low cardiac output, not first-line vasopressor |
Why the other options are not first-line
Watch out! Dobutamine primarily increases cardiac contractility and can worsen hypotension by causing peripheral vasodilation. It is not appropriate as the initial agent for a client whose main problem is low vascular tone.
Key point! Vasopressin is a second-line add-on therapy, not the first vasopressor. A meta-analysis comparing vasopressin with norepinephrine as first-line therapy did not establish vasopressin as the preferred initial agent, and current practice retains norepinephrine in that role
[1][2].
Clinical application
After fluid resuscitation, if the mean arterial pressure remains below 65 mmHg, norepinephrine is initiated and titrated to achieve that target. The nurse monitors blood pressure response, urine output, lactate clearance, and signs of peripheral hypoperfusion. Because prolonged high-dose catecholamine exposure carries dose-dependent cardiac, metabolic, and immunologic risks, the clinical team considers adding vasopressin early to limit norepinephrine exposure rather than escalating norepinephrine alone
[2][3]. This catecholamine-sparing approach is an emerging focus in septic shock management, but it does not change the first-line status of norepinephrine
[2][3][4].
References (research sources)
- [1]
Vasopressin versus norepinephrine as the first-line vasopressor in septic shock: A systematic review and meta-analysis.Meta-analysis/systematic reviewSedhai YR, Shrestha DB, Budhathoki P, Memon W, Acharya R, Gaire S (2022)
- [2]
Current and future strategies aiming at reducing catecholamine exposure in septic shock.Research articleDubech A, Picod A, Pierre A, Preau S, Favory R, Garcia B. (2026) · DOI: 10.1186/s13054-026-06109-3
- [3]
Mechanistic Assessment of Norepinephrine Therapy versus Angiotensin-II in Septic Shock (MANTRA): Study Protocol for a multicenter randomized trialRCT/clinical trialFilbin MR, Leisman DE, Pachano-Bravo A, Goldberg MB, Hibbert K, Nelson O, Rappaport B, Mahler SA, Harris L, Besong EB, Reeves B, Maves RC, Petrilli A, Schaich CL, Files DC, Gibbs K, Chappell MC, Khanna AK. (2026) · DOI: 10.64898/2026.09.12.26362906
- [4]
Emergency medicine updates: Management of sepsis and septic shock.Research articleLong B, Gottlieb M (2025) · DOI: 10.1016/j.ajem.2025.01.054